Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Prognostic significance of grading (MIB-1 system) in patients with myxoid liposarcoma.

Tateishi U, Hasegawa T, Beppu Y, Kawai A, Moriyama N.

J Clin Pathol. 2003 Aug;56(8):579-82.

2.

Prognostic significance of grading and staging systems using MIB-1 score in adult patients with soft tissue sarcoma of the extremities and trunk.

Hasegawa T, Yamamoto S, Yokoyama R, Umeda T, Matsuno Y, Hirohashi S.

Cancer. 2002 Aug 15;95(4):843-51.

3.

Prognostic significance of MRI findings in patients with myxoid-round cell liposarcoma.

Tateishi U, Hasegawa T, Beppu Y, Kawai A, Satake M, Moriyama N.

AJR Am J Roentgenol. 2004 Mar;182(3):725-31.

PMID:
14975976
5.

Clinicopathologic prognostic factors in myxoid liposarcoma: a retrospective study of 49 patients with long-term follow-up.

ten Heuvel SE, Hoekstra HJ, van Ginkel RJ, Bastiaannet E, Suurmeijer AJ.

Ann Surg Oncol. 2007 Jan;14(1):222-9. Epub 2006 Oct 22.

PMID:
17058128
6.

Frequent alteration of p16(INK4a)/p14(ARF) and p53 pathways in the round cell component of myxoid/round cell liposarcoma: p53 gene alterations and reduced p14(ARF) expression both correlate with poor prognosis.

Oda Y, Yamamoto H, Takahira T, Kobayashi C, Kawaguchi K, Tateishi N, Nozuka Y, Tamiya S, Tanaka K, Matsuda S, Yokoyama R, Iwamoto Y, Tsuneyoshi M.

J Pathol. 2005 Dec;207(4):410-21.

PMID:
16177957
7.

Prognostic relevance of proliferative activity evaluated by Mib-1 immunostaining in node negative breast cancer.

Neri A, Marrelli D, Pedrazzani C, Caruso S, De Stefano A, Mariani F, Megha T, De Marco G, Corso G, Pinto E, Roviello F.

Eur J Surg Oncol. 2008 Dec;34(12):1299-303. doi: 10.1016/j.ejso.2007.11.009. Epub 2008 Mar 4.

PMID:
18164172
8.

Prognostic relevance of a histological grading system using MIB-1 for adult soft-tissue sarcoma.

Hasegawa T, Yokoyama R, Lee YH, Shimoda T, Beppu Y, Hirohashi S.

Oncology. 2000;58(1):66-74.

PMID:
10644943
9.

Clinicopathologic prognostic factors of pure myxoid liposarcoma of the extremities and trunk wall.

Nishida Y, Tsukushi S, Nakashima H, Ishiguro N.

Clin Orthop Relat Res. 2010 Nov;468(11):3041-6. doi: 10.1007/s11999-010-1396-3.

10.

The association between tumour progression and vascularity in myxofibrosarcoma and myxoid/round cell liposarcoma.

Mentzel T, Brown LF, Dvorak HF, Kuhnen C, Stiller KJ, Katenkamp D, Fletcher CD.

Virchows Arch. 2001 Jan;438(1):13-22.

PMID:
11213831
11.

Myxoid/round cell and pleomorphic liposarcomas: prognostic factors and survival in a series of patients treated at a single institution.

Fiore M, Grosso F, Lo Vullo S, Pennacchioli E, Stacchiotti S, Ferrari A, Collini P, Lozza L, Mariani L, Casali PG, Gronchi A.

Cancer. 2007 Jun 15;109(12):2522-31.

13.

MIB-1 as a proliferative marker in transitional cell carcinoma of the bladder: clinical significance and comparison with other prognostic factors.

Oosterhuis JW, Schapers RF, Janssen-Heijnen ML, Smeets AW, Pauwels RP.

Cancer. 2000 Jun 1;88(11):2598-605.

PMID:
10861439
14.

Prognostic significance of Ki-67/MIB-1 proliferation index in meningiomas.

Torp SH, Lindboe CF, Grønberg BH, Lydersen S, Sundstrøm S.

Clin Neuropathol. 2005 Jul-Aug;24(4):170-4.

PMID:
16033133
15.
16.
17.

Validation of immature adipogenic status and identification of prognostic biomarkers in myxoid liposarcoma using tissue microarrays.

Cheng H, Dodge J, Mehl E, Liu S, Poulin N, van de Rijn M, Nielsen TO.

Hum Pathol. 2009 Sep;40(9):1244-51. doi: 10.1016/j.humpath.2009.01.011. Epub 2009 Apr 14.

PMID:
19368956
18.

MIB-1 labelling index is an independent prognostic marker in primary breast cancer.

Jansen RL, Hupperets PS, Arends JW, Joosten-Achjanie SR, Volovics A, Schouten HC, Hillen HF.

Br J Cancer. 1998 Aug;78(4):460-5.

19.

Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases.

Antonescu CR, Tschernyavsky SJ, Decuseara R, Leung DH, Woodruff JM, Brennan MF, Bridge JA, Neff JR, Goldblum JR, Ladanyi M.

Clin Cancer Res. 2001 Dec;7(12):3977-87.

20.

Molecular markers for predicting prostate cancer stage and survival.

Dunsmuir WD, Gillett CE, Meyer LC, Young MP, Corbishley C, Eeles RA, Kirby RS.

BJU Int. 2000 Nov;86(7):869-78.

Supplemental Content

Support Center